Acorda Therapeutics, Inc. financial data

Location
Pearl River, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q1 2024 - 14 May 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 50% % -74%
Quick Ratio 12% % -67%
Return On Equity 486% %
Return On Assets -114% % -671%
Operating Margin -236% % -828%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,242,098 shares -95%
Common Stock, Value, Issued $1,000 USD -96%
Weighted Average Number of Shares Outstanding, Basic 1,242,000 shares 0%
Weighted Average Number of Shares Outstanding, Diluted 1,242,000 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $115,664,000 USD -2.2%
Research and Development Expense $4,720,000 USD -14%
Costs and Expenses $388,768,000 USD 162%
Operating Income (Loss) $273,104,000 USD -807%
Nonoperating Income (Expense) $31,336,000 USD -11793%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $304,440,000 USD -920%
Income Tax Expense (Benefit) $41,015,000 USD -245%
Net Income (Loss) Attributable to Parent $263,425,000 USD -352%
Earnings Per Share, Basic -212 USD/shares -176%
Earnings Per Share, Diluted -212 USD/shares -176%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $9,364,000 USD -69%
Accounts Receivable, after Allowance for Credit Loss, Current $9,188,000 USD -0.02%
Inventory, Net $14,119,000 USD 4.9%
Other Assets, Current $2,447,000 USD -40%
Assets, Current $48,453,000 USD -29%
Property, Plant and Equipment, Net $1,893,000 USD -21%
Operating Lease, Right-of-Use Asset $3,941,000 USD -22%
Intangible Assets, Net (Excluding Goodwill) $22,343,000 USD -92%
Other Assets, Noncurrent $4,690,000 USD 213%
Assets $81,575,000 USD -78%
Accounts Payable, Current $9,932,000 USD 248%
Accrued Liabilities, Current $17,665,000 USD -35%
Liabilities, Current $223,936,000 USD 545%
Deferred Income Tax Liabilities, Net $0 USD -100%
Operating Lease, Liability, Noncurrent $2,847,000 USD -30%
Other Liabilities, Noncurrent $8,035,000 USD -14%
Accumulated Other Comprehensive Income (Loss), Net of Tax $875,000 USD 22%
Retained Earnings (Accumulated Deficit) $1,216,522,000 USD -28%
Stockholders' Equity Attributable to Parent $185,771,000 USD -341%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $185,771,000 USD -341%
Liabilities and Equity $81,575,000 USD -78%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $20,185,000 USD -188%
Common Stock, Shares Authorized 3,083,333 shares -95%
Common Stock, Shares, Issued 1,242,376 shares -95%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $20,278,000 USD -193%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10,337,000 USD -73%
Operating Lease, Liability $4,447,000 USD -21%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $263,269,000 USD -362%
Lessee, Operating Lease, Liability, to be Paid $5,041,000 USD -24%
Operating Lease, Liability, Current $1,599,000 USD 2.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,678,000 USD 2.8%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,633,000 USD 2.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $594,000 USD -40%
Lessee, Operating Lease, Liability, to be Paid, Year Three $357,000 USD -79%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $182,000 USD -49%
Operating Lease, Payments $397,000 USD 2.8%
Amortization of Intangible Assets $23,717,000 USD -23%
Depreciation, Depletion and Amortization $882,000 USD -89%
Share-based Payment Arrangement, Expense $537,000 USD -50%
Interest Expense $32,398,000 USD 7.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%